Genetic analysis of CD28 signaling

Immunologic Research

Volumn 27, Issue 2-3, 2003, Pages 513-520

  Greene, Tiffani A ^a   Shapiro, Virginia Smith ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CD28; RE AP; Signal transduction

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; BIOCHEMISTRY; GENE EXPRESSION; GENE LIBRARY; GENE OVEREXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; IMMUNOSTIMULATION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; HUMANS; LYMPHOCYTE ACTIVATION; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0042520923     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:27:2-3:513     Document Type: Review

References (48)

1. Chambers CA, Allison JP: Costimulation in T cell responses. Curr Opin Immunol 1997;9: 396-404.
2. Schwartz RH: T cell clonal anergy. Curr Opin Immunol 1997;9: 351-357.
3. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-609.
4. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunology Today 1994;15:321-331.
5. Watts TH, DeBenedette MA: T cell co-stimulatory molecules other than CD28. Curr Op Imm 1999;11: 286-293.
6. Borriello F, Sethna MP, Boyd SD, et al.: B7-1 and B7-2 have overlapping, critical roles for immunoglobulin class switching and germinal center formation. Immunity 1997;6:303-313.
7. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB: Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994;1: 501-508.
8. Shahinian A, Pfeffer K, Lee KP, et al.: Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261: 609-612.
9. Riegel JS, Corthesy B, Flanagan WM, Crabtree GR: Regulation of the interleukin-2 gene. Chem Immunol 1992;51:266-298.
10. Fraser JD, Irving BA, Crabtree GR, Weiss A: Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991;251:313-316.
11. Shapiro VS, Truitt KE, Imboden JB, Weiss A: CD28 mediates transcriptional upregualtion of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol Cell Biol 1997;17:4051-4058.
12. Shapiro VS, Mollenauer MN, Weiss A: Endogenous CD28 expressed on myeloma cells upregulates interleukin-8 production: implications for multiple myeloma progression. Blood 2001;98: 187-193.
13. Shapiro VS, Mollenauer MN, Weiss A: Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP. J Immunol 1998;161: 4051-4058.
14. Holdorf AD, Kanagawa O, A.S. Shaw AS: CD28 and T cell co-stimulation. Rev Immunogen 2000;2:175-184.
15. Ward SG: CD28: a signaling perspective. Biochem J 1996;318: 361-377.
16. Ruland J, Duncan GS, Elia A, et al.: Bc110 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 2001;104:33-42.
17. Sun Z, Arendt CW, Ellmeier W, et al.: PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature lymphocytes. Nature 2000;404:402-407.
18. Bachmaier K, Krawczyk C, Kozieradzki I, et al.: Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 2000;403:211-216.
19. Chiang Y., Kole HK, Brown K, et al.: Cbl-b regulates the CD28 dependence of T-cell activation. Nature 2000;403:216-220.
20. Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A: Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN gamma but not Th2 cytokines. Nat Immunol 2001;2:37-44.
21. Burr JS, Savage NDL, Messah GE, Kimzey SL, Shaw AS, Green JM: Distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol 2001;166:5331-5335.
22. Harada Y, Tolishima M, Matsumoto Y, et al.: Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J Immunol 2001;166: 3797-3803.
23. Okkenhaug K, Wu L, Garza KM, et al.: A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol 2001;2:325-332.
24. Sadra A, Cinek T, Arellano JL, Shi J, Truitt KE, Imboden JB: Identification of tyrosine phosphorylation sites in the CD28 cytoplasmic domain and their role in the costimulation of Jurkat T cells. J Immunol 1999;162:1966-1973.
25. Chuang E, Fisher TS, Morgan RW, et al.: The CD28 and CTLA-4 receptors associate with the serine/ threonine phosphatase PP2A. Immunity 2000;13:313-322.
26. Marengere LE, Okkenhaug K, Clavreul A, Couez D, Gibson S, Mills GB, Rottapel R: The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J Immunol 1997;159:3220-3229.
27. Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE: p561ck and p59fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2 and T cell-specific ptoein-tyrosine kinase ITK: implications for T cell costimulation. Proc Natl Acad Sci USA 1995;92:8891-8895.
28. Holdorf AD, Green JM, Levin SD, et al.: Proline residues in CD28 and the Src Homology (SH) 3 domain of Lck are required for T cell costimulation. J Exp Med 1999;190: 375-384.
29. Goldsmith MA, Weiss A: Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc Natl Acad Sci USA 1987;84:6879-6883.
30. Finco TS, Kadlecek T, Zhang W, Samelson LE, Weiss A: LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 1998;9: 617-626.
31. Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT: Pleitropic contributions of phospholipase C-gamma 1 (PLC-gammal) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gammal-deficient Jurkat T-cell line. Mol Cell Biol 2000;20: 9149-9161.
32. Straus DB, Weiss A: Genetic evidence for the involvement of the ick tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992;70:585-593.
33. Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ, Abraham RT: Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70 deficient Jurkat T-cell line. Mol Cell Biol 1998;18: 1388-1399.
34. Yablonski D, Kuhne MR, Kadlecek T, Weiss A: Uncoupling of nonreceptor kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 1998;281:413-416.
35. Iwashima M, Takamatsu M, Yamagishi H, et al.: Genetic evidence for Shc requirement, in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc Natl Acad Sci USA 2002;99: 4544-4549.
36. Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA: Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 1998;281:416-419.
37. Molina TJ, Kishihara K, Siderovski DP, et al.: Profound block in thymocyte development in mice lacking p561ck. Nature 1992;357: 161-164.
38. Negishi I, Motoyama N, Nakayama K, et al.: Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 1995;376:435-438.
39. Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS: Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 1998;94:229-238.
40. Zhang W, Sommers CL, Burshtyn DN, et al.: Essential role of LAT in T cell development. Immunity 1999;10:323-332.
41. Stark GR, Gudkov AV: Forward genetic analysis in mammalian cells: functional approaches to gene discovery. Hum Mol Gen 1999;8:1925-1938.
42. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S: Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995;9:1965-1977.
43. Butscher WG, Powers C, Olive M, Vinson C, Gardner K: Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J Biol Chem 1998;273:552-560.
44. McGuire KL, Iacobelli M: Involvement of Rel, Fos and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J Immunol 1997;159: 1319-1327.
45. Sun P, Dong P, Dai K, Hannon GJ, Beach D: p53-independent role of MDM2 in TGF-beta1 resistance. Science 1998;282:2270-2272.
46. Holland SJ, Liao XC, Mendenhall MK, et al.: Functional cloning of Src-like adaptor protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling. J Exp Med 2001;194: 1263-1276.
47. Mahlmann S, McLaughlin J, Afar DE, Mohn R, Kay RJ, Witte ON: Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection. Leukemia 1998;12:1858-1865.
48. Velazquez L, Fellous M, Stark GR, Pellegrini S: A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 1992;70: 313-322.